Cangene (FRA:YGE) Scaled Net Operating Assets : 0.51 (As of Oct. 2013)

View and export this data going back to . Start your Free Trial

What is Cangene Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Cangene's operating assets for the quarter that ended in Oct. 2013 was €180.49 Mil. Cangene's operating liabilities for the quarter that ended in Oct. 2013 was €68.27 Mil. Cangene's Total Assets for the quarter that ended in Jul. 2013 was €218.90 Mil. Therefore, Cangene's scaled net operating assets (SNOA) for the quarter that ended in Oct. 2013 was 0.51.

Cangene Scaled Net Operating Assets Historical Data

The historical data trend for Cangene's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cangene Scaled Net Operating Assets Chart

Cangene Annual Data

Trend

Jul04

Jul05

Jul06

Jul07

Jul08

Jul09

Jul10

Jul11

Jul12

Jul13

Scaled Net Operating Assets

Get a 7-Day Free Trial

0.89

0.63

0.58

0.70

0.61

Cangene Quarterly Data
	Jan09	Apr09	Jul09	Oct09	Jan10	Apr10	Jul10	Oct10	Jan11	Apr11	Jul11	Oct11	Jan12	Apr12	Jul12	Oct12	Jan13	Apr13	Jul13	Oct13
Scaled Net Operating Assets	Get a 7-Day Free Trial															0.67	0.64	0.69	0.51	0.51

Competitive Comparison of Cangene's Scaled Net Operating Assets

For the Biotechnology subindustry, Cangene's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cangene's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cangene's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Cangene's Scaled Net Operating Assets falls into.

Cangene Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Cangene's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Jul. 2013 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Jul. 2013 )
=	(Operating Assets (A: Jul. 2013 )	-	Operating Liabilities (A: Jul. 2013 ))	/	Total Assets (A: Jul. 2012 )
=	(183.443	-	68.462)	/	188.822
=	0.61

where

	Operating Assets		(A: Jul. 2013 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	218.9	-	35.457
=	183.443

	Operating Liabilities		(A: Jul. 2013 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	68.462	-	0	-	0
=	68.462

Cangene's Scaled Net Operating Assets (SNOA) for the quarter that ended in Oct. 2013 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Oct. 2013 )
=	(Operating Assets (Q: Oct. 2013 )	-	Operating Liabilities (Q: Oct. 2013 ))	/	Total Assets (Q: Jul. 2013 )
=	(180.486	-	68.269)	/	218.9
=	0.51

where

	Operating Assets		(Q: Oct. 2013 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	208.847	-	28.361
=	180.486

	Operating Liabilities		(Q: Oct. 2013 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	68.269	-	0	-	0
=	68.269

Cangene Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Cangene's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Cangene (FRA:YGE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cangene Corporation (FRA:YGE) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.cangene.com

Cangene Corporation is a fully integrated developer and manufacturer of immune therapeutics, primarily targeting infectious disease, hematology, transplantation and biodefense applications. The company manages its business and evaluate performance based on two operating segments: biopharmaceutical operations and contract services. Revenues are generated from product sales, and contract manufacturing and contract-R&D services.

Cangene (FRA:YGE) Headlines

No Headlines